Evidence map›Paper›PMID 38978335›Full record

ArticleESC heart failure2024

Incidence of clinical outcomes in heart failure patients with and without advanced chronic kidney disease.

Deewa Zahir Anjum, Anders N Bonde, Emil Fosbol, Caroline Hartwell Garred, Gunnar Gislason, Mariam Elmegaard, Pauline Knigge, Christian Torp-Pedersen, Charlotte Andersson, Marc A Pfeffer and 5 more

Abstract read
In one paragraph

Article in ESC heart failure, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Observational
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Deewa Zahir AnjumDepartment of Cardiology, Copenhagen University Hospital, Hellerup, Denmark.ORCID 0000-0001-9564-6231
Anders N BondeDepartment of Cardiology, Copenhagen University Hospital, Hellerup, Denmark.
Emil FosbolDepartment of Cardiology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
Caroline Hartwell GarredDepartment of Cardiology, Copenhagen University Hospital, Hellerup, Denmark.
Gunnar GislasonDepartment of Cardiology, Copenhagen University Hospital, Hellerup, Denmark.
Mariam ElmegaardDepartment of Cardiology, Copenhagen University Hospital, Hellerup, Denmark.
Pauline KniggeDepartment of Cardiology, Copenhagen University Hospital, Hellerup, Denmark.
Christian Torp-PedersenDepartment of Clinical Research and Cardiology, Nordsjællands Hospital, Hillerød, Denmark.
Charlotte AnderssonDepartment of Cardiology, Copenhagen University Hospital, Hellerup, Denmark.
Marc A PfefferCardiovascular Division, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Pardeep S JhundBHF Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.
John J V McMurrayBHF Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.
Mark C PetrieBHF Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.
Lars KoberDepartment of Cardiology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
Morten SchouDepartment of Cardiology, Copenhagen University Hospital, Hellerup, Denmark.

Funding

Region Hovedstaden
6 · The paper itself

Abstract

aimsChronic kidney disease (CKD) is a well-established risk factor for heart failure (HF); however, patients with an estimated glomerular filtration rate (eGFR) < 30 mL/min/1.73 m

methodsFrom nationwide registries, HF patients were identified from 2014 to 2018 and categorized into three groups according to baseline eGFR (eGFR ≥ 60, 60 > eGFR ≥ 30 and eGFR < 30). The incidence of primary outcomes (all-cause mortality, HF hospitalization, end-stage kidney disease and sustained 50% eGFR decline) was estimated using cumulative incidence functions.

resultsOf the 21 959 HF patients included, the median age was 73.9 years, and 30% of patients had an eGFR between 30 and 60 and 7% had an eGFR < 30. The 4 year incidence of all-cause mortality was highest for patients with eGFR < 30 (28.3% for patients with eGFR ≥ 60, 51.6% for patients with 60 > eGFR ≥ 30 and 72.2% for patients with eGFR < 30). The 4 year incidence of HF hospitalization was comparable between the groups (25.8%, 29.8% and 26.1% for patients with eGFR ≥ 60, 60 > eGFR ≥ 30 and eGFR < 30, respectively). For patients with eGFR < 30, kidney outcomes were four times more often the first event than patients with eGFR > 30 (4 year incidence of kidney outcome as the first event was 5.0% for eGFR ≥ 60, 4.8% for 60 > eGFR ≥ 30 and 20.1% for eGFR < 30).

conclusionsPatients with advanced CKD had a higher incidence of mortality and poorer kidney outcomes than those without advanced CKD, but a similar incidence of HF hospitalizations.

Indexed as

Glomerular Filtration RateHeart FailureRegistriesRenal Insufficiency, ChronicAgedCause of DeathFemaleFollow-Up StudiesHospitalizationHumansIncidenceMaleMiddle AgedPrognosisRepublic of KoreaRetrospective Studieschronic kidney diseaseepidemiologyheart failurerenal endpoints

Identifiers

PMID38978335
PMCPMC11424275

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.